Corcept Therapeutics
CORT
CORT
225 hedge funds and large institutions have $1.81B invested in Corcept Therapeutics in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 94 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
225
Holders Change
-7
Holders Change %
-3.02%
% of All Funds
3.55%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
27
Increased
64
Reduced
94
Closed
34
Calls
$2.07M
Puts
$1.48M
Net Calls
+$596K
Net Calls Change
+$14.1M
Top Buyers
| 1 |
Man Group
London,
United Kingdom
|
$13.7M |
| 2 |
D.E. Shaw & Co
New York
|
$25.6M |
| 3 |
Two Sigma Advisers
New York
|
$6.93M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
$6.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$8.97M |
Top Sellers
| 1 |
Millennium Management
New York
|
$19.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$207M |
| 3 |
BlackRock
New York
|
$340M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
$492K |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
$14.7K |
